Cardiometabolic Risk Factors in Pregnancy and Implications for Long-Term Health: Identifying the Research Priorities...

Area of Science:

• Global Health
• Cardiology
• Obstetrics & Gynecology

Background:

• Cardiometabolic disorders (CMDs) are leading causes of death and illness in women globally.
• These disorders disproportionately impact low and middle-income countries (LMICs), presenting earlier and with higher fatality rates.
• Pregnancy complications like hypertensive disorders of pregnancy (HDPs) and gestational diabetes mellitus (GDM) signal increased future CMD risk.

Purpose of the Study:

• To review challenges in identifying and managing pregnant women at risk for CMDs in low-resource settings.
• To present evidence-based strategies, including novel diagnostics and technologies, for early detection and management.
• To highlight research priorities for addressing cardiometabolic risk during pregnancy in LMICs.

Main Methods:

• Mini-review of existing literature and evidence-based strategies.
• Focus on challenges in early identification, referral, and management.
• Exploration of novel diagnostics, technology, and innovations.

Main Results:

• Significant challenges exist in the early identification, referral, and management of pregnant women at risk for CMDs in LMICs.
• Evidence-based strategies and innovations are available for early detection and management.
• Key research priorities have been identified to address cardiometabolic risk in pregnancy.

Conclusions:

• Early identification and postpartum follow-up of women with pregnancy complications are crucial for CMD prevention or delay.
• Implementing innovative strategies and addressing research priorities are essential for improving outcomes in low-resource settings.
• Targeting cardiometabolic risk in pregnancy offers a vital window for intervention and long-term women's health improvement.